Atlas Trials

Bioequivalence Study of Oxcarbazepine Oral Suspension 300 mg/5 mL Under Fasting Conditions

Clinical trial NCT00951600 · COMPLETED

Trial details

NCT number
NCT00951600
Sponsor
Ranbaxy Laboratories Limited
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Healthy
Start date
2006-09-01
Primary completion
2006-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.